These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7477335)

  • 1. Corticotropin-releasing factor. From stress to cognition.
    Lightman SL
    Nature; 1995 Nov; 378(6554):233-4. PubMed ID: 7477335
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acute neurogenic stress on hypothalamic corticotropin-releasing factor content.
    Chowers I; Conforti N; Siegel R; Feldman S
    Isr J Med Sci; 1973 Aug; 9(8):1056-8. PubMed ID: 4356730
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours.
    Venihaki M; Sakihara S; Subramanian S; Dikkes P; Weninger SC; Liapakis G; Graf T; Majzoub JA
    J Neuroendocrinol; 2004 May; 16(5):411-22. PubMed ID: 15117334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential uses of corticotropin-releasing hormone antagonists.
    Zoumakis E; Rice KC; Gold PW; Chrousos GP
    Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?
    Gysling K; Forray MI; Haeger P; Daza C; Rojas R
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in hypothalamic content of corticotropin-releasing activity following stress during neonatal maturation in the rat.
    Hiroshige T; Sato T
    Neuroendocrinology; 1971; 7(5):257-70. PubMed ID: 5314499
    [No Abstract]   [Full Text] [Related]  

  • 8. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats.
    Iwasa T; Matsuzaki T; Kiyokawa M; Shimizu F; Minakuchi M; Kuwahara A; Maegawa M; Yasui T; Irahara M
    J Neuroendocrinol; 2007 Sep; 19(9):732-8. PubMed ID: 17680889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corticotropin-releasing hormone in the regulation of adaptive behavior].
    Shaliapina VG; Rakitskaia VV; Rybnikova EA
    Usp Fiziol Nauk; 2003; 34(4):75-92. PubMed ID: 14658304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the components of the central response to stress.
    Mayer EA; Fanselow MS
    Nat Neurosci; 2003 Oct; 6(10):1011-2. PubMed ID: 14513035
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Bale TL; Contarino A; Smith GW; Chan R; Gold LH; Sawchenko PE; Koob GF; Vale WW; Lee KF
    Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
    Huang Q; Timofeeva E; Richard D
    J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.
    Hsu SY; Hsueh AJ
    Nat Med; 2001 May; 7(5):605-11. PubMed ID: 11329063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
    Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
    Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of stress and dexamethasone on the amount of CRF-granulas in the infundibulum of adrenalectomized rats].
    Schwabedal PE
    Verh Anat Ges; 1975; 69():705-10. PubMed ID: 1084638
    [No Abstract]   [Full Text] [Related]  

  • 19. [Placental corticotropin releasing-hormone and urocortin--possible role in mechanism of preterm labor].
    Meczekalski B
    Pol Merkur Lekarski; 2006 Oct; 21(124):398-400. PubMed ID: 17205787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.
    Behan DP; Heinrichs SC; Troncoso JC; Liu XJ; Kawas CH; Ling N; De Souza EB
    Nature; 1995 Nov; 378(6554):284-7. PubMed ID: 7477348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.